Remove Bioequivalency Remove Manufacturing Remove Reagent
article thumbnail

Revised Final Guidance on Nitrosamines Offers New Recommendations for Assessment and Control

FDA Law Blog

Nitrosamines are impurities that can form during drug manufacturing and are considered potentially potent carcinogens. For example, depending on the manufacturing process for a specific human drug, the use of some specific solvents, reagents, and catalysts may trigger the formation of these possible carcinogens.